Last reviewed · How we verify

NCT06157424

Efficacy and Safety of Combined Thread Embedding Acupuncture With Auricular Acupuncture for GERD

Completed NA Last updated 20 March 2024
What this trial tests

NA trial testing Thread Embedding Acupuncture in GERD in 66 participants. Completed in 18 March 2024.

Timeline
6 December 2023
Primary endpoint
18 March 2024
18 March 2024

Quick facts

Lead sponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment66
Start date6 December 2023
Primary completion18 March 2024
Estimated completion18 March 2024
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

University of Medicine and Pharmacy at Ho Chi Minh City

Who can join

Adults 18 to 60, any sex, with GERD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gastroesophageal reflux disease (GERD) is increasingly prevalent today. Proton-pump inhibitors (PPIs) are the primary treatment, yet their effectiveness remains limited. Various acupuncture methods have shown promise in treating GERD. Among these, thread embedding acupuncture (TEA) and auricular acupuncture (AA) offer the advantage of prolonged treatment per intervention, significantly reducing healthcare visits for procedures, particularly beneficial for conditions requiring extended therapy. This has led to the widespread application of TEA and AA in GERD treatment. However, evidence supporting their effectiveness remains inconclusive. In this study, we aim to assess the efficacy and safety of combining TEA with AA for treating GERD. According to traditional medicine, treatment should be pattern-based. Thus, we will focus on patients exhibiting the Liver Qi Invading Stomach pattern, as reports indicate its prevalence among GERD patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Systematic mapping of registered interventional studies addressing the top 10 research priorities in Barrett's oesophagus and gastro-oesophageal reflux disease.
    Gamakaranage C, Ratcliffe E, Britton J, Butler T, et al · · 2025 · PMID 40527525 · DOI 10.1136/bmjgast-2025-001738

Verify or expand the search:

Other recruiting trials for GERD

Currently open trials in the same condition.

Other University of Medicine and Pharmacy at Ho Chi Minh City trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06157424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing